GSK3B and glucose metabolism disease: The molecular mechanism of a GnIH-induced glucose metabolic disorder revealed that GnIH impaired the glucose homeostasis via the affect the AKT-GSK-3β signaling cascade had to alter the function and morphology of the pancreas islets, impair the glucose transport and cause an insulin signal transduction in the liver and WAT (Figure 8).